METHODS: This study was conducted on data gathered from 181 participants in the NAVIGATE I and NAVIGATE II randomized control trials within the OPTINOSE database. Participants were analyzed based on sex controlling for airway-related comorbidities, including history of asthma, race, and ethnicity. SNOT-22 scores were assessed as a quality-of-life outcome measure for CRS. The association between sex and SNOT-22 scores was determined using multiple linear regression.
RESULTS: There were 81 female and 100 male participants. SNOT-22 scores were significantly higher in females. The average reported SNOT-22 score was 53.8 ± 16.5 in females and 46.8 ± 18.8 in males. On adjusted regression, the association of sex and SNOT-22 scores approached but didn\'t reach significance (β: -4.97; 95 % CI: -10.68-0.73; p = 0.09).
CONCLUSIONS: On average, females had more severe manifestations of CRSwNP in comparison to males, with the adjusted association approaching statistical significance. Further studies, potentially looking at hormones as a cause of pathogenesis, are needed to better elucidate the role of sex in CRSwNP.
方法:本研究基于OPTINOSE数据库中的NAVIGATEI和NAVIGATEII随机对照试验的181名参与者收集的数据进行。参与者根据气道相关合并症的性别控制进行分析,包括哮喘病史,种族,和种族。SNOT-22评分被评估为CRS的生活质量结果指标。使用多元线性回归确定性别与SNOT-22评分之间的关联。
结果:有81名女性和100名男性参与者。女性的SNOT-22得分明显较高。女性报告的SNOT-22平均得分为53.8±16.5,男性为46.8±18.8。在调整后的回归中,性别与SNOT-22评分的相关性接近但未达到显著性(β:-4.97;95%CI:-10.68-0.73;p=0.09)。
结论:平均而言,与男性相比,女性的CRSwNP表现更严重,调整后的关联接近统计意义。进一步研究,可能将激素视为发病机理的原因,需要更好地阐明性别在CRSwNP中的作用。